Basic Information
LncRNA/CircRNA Name | MALAT1 |
Synonyms | MALAT1, HCN, LINC00047, NCRNA00047, NEAT2, PRO2853 |
Region | GRCh38_11:65497688-65506516 |
Ensemble | ENSG00000251562 |
Refseq | NR_002819 |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | Drug | |||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | oral squamous cell carcinoma |
ICD-0-3 | C06.9 |
Methods | qPCR, RNAi, Western blot etc. |
Sample | OSCC tissues, cell lines (Tscca, Tca8113P160, Tca8113, Hep-2) |
Expression Pattern | up-regulated |
Function Description | We found that MALAT1 is overexpressed in OSCC tissues compared to normal oral mucosa by real-time PCR. MALAT1 served as a new prognostic factor in OSCC patients. When knockdown by small interfering RNA (siRNA) in OSCC cell lines TSCCA and Tca8113, MALAT1 was shown to be required for maintaining epithelial-mesenchymal transition (EMT) mediated cell migration and invasion. Western blot and immunofluorescence staining showed that MALAT1 knockdown significantly suppressed N-cadherin and Vimentin expression but induced E-cadherin expression in vitro. Meanwhile, both nucleus and cytoplasm levels of B-catenin and NF-B were attenuated, while elevated MALAT1 level triggered the expression of B-catenin and NF-??. More importantly, targeting MALAT1 inhibited TSCCA cell-induced xenograft tumor growth in vivo. |
Pubmed ID | 26522444 |
Year | 2015 |
Title | Long Non Coding RNA MALAT1 Promotes Tumor Growth and Metastasis by inducing Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma. |
External Links
Links for MALAT1 | GenBank HGNC NONCODE |
Links for oral squamous cell carcinoma | OMIM COSMIC |